96 related articles for article (PubMed ID: 16437614)
21. Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism.
Yu L; Sun Y; Li J; Wang Y; Zhu Y; Shi Y; Fan X; Zhou J; Bao Y; Xiao J; Cao K; Cao P
J Exp Clin Cancer Res; 2017 Aug; 36(1):110. PubMed ID: 28810896
[TBL] [Abstract][Full Text] [Related]
22. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
[TBL] [Abstract][Full Text] [Related]
23. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS
Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
25. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma.
Zhang T; Sun J; He W; Li H; Piao J; Xu H; Duan X
BMC Cancer; 2018 Apr; 18(1):451. PubMed ID: 29678159
[TBL] [Abstract][Full Text] [Related]
27. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.
Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Br J Radiol; 2007 Mar; 80(951):194-201. PubMed ID: 17038412
[TBL] [Abstract][Full Text] [Related]
28. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
[TBL] [Abstract][Full Text] [Related]
29. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.
Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H
Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle and radiosensitivity of progeny of irradiated primary cultured human hepatocarcinoma cells.
Liu ZZ; Huang WY; Lin JS; Li XS; Liang KH; Huang JL
World J Gastroenterol; 2005 Nov; 11(44):7033-5. PubMed ID: 16437612
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between the radiosensitivity of hepatic carcinoma cells and their survivin expression levels].
Ma XJ; Chen XP
Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):207-9. PubMed ID: 18364081
[TBL] [Abstract][Full Text] [Related]
32. [Interval of radiosensitivity as a basis of therapeutic irradiation of malignant tumors].
Kholin VV
Med Radiol (Mosk); 1973 Dec; 18(12):71-7. PubMed ID: 4364513
[No Abstract] [Full Text] [Related]
33. Radiosensitivity in multidrug-resistant and cisplatin-resistant human carcinoma cell lines.
Gigante M; Toffoli G; Bertola A; Biscontin G; Dassie A; Zanelli GD; Zanin E; Trovò MG; Muzzio PC
Am J Clin Oncol; 2003 Aug; 26(4):e73-9. PubMed ID: 12902902
[TBL] [Abstract][Full Text] [Related]
34. External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation.
Yamashita H; Nakagawa K; Shiraishi K; Tago M; Igaki H; Nakamura N; Sasano N; Shiina S; Omata M; Ohtomo K
J Gastroenterol Hepatol; 2006 Oct; 21(10):1555-60. PubMed ID: 16928216
[TBL] [Abstract][Full Text] [Related]
35. [Hepatic arterial infusion of 32P-radionuclide microspheres for radiation therapy of hepatocellular carcinoma].
Liang L; Huang J; Yin X; Lu M; Rao G; Ren Z; Li D; Kuang M
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):743-6. PubMed ID: 11829942
[TBL] [Abstract][Full Text] [Related]
36. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
[TBL] [Abstract][Full Text] [Related]
37. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.
Kim EH; Kim MS; Furusawa Y; Uzawa A; Han S; Jung WG; Sai S
Oncotarget; 2016 Dec; 7(49):80568-80578. PubMed ID: 27802188
[TBL] [Abstract][Full Text] [Related]
38. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
[TBL] [Abstract][Full Text] [Related]
39. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
40. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
